A detailed history of Matrix Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Matrix Trust CO holds 13,419 shares of ABBV stock, worth $2.37 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
13,419
Previous 13,317 0.77%
Holding current value
$2.37 Million
Previous $2.28 Million 16.02%
% of portfolio
0.5%
Previous 0.52%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $16,711 - $20,331
102 Added 0.77%
13,419 $2.65 Million
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $13,776 - $16,087
89 Added 0.67%
13,317 $2.28 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $2,237 - $2,549
14 Added 0.11%
13,228 $2.41 Million
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $12,108 - $13,637
-88 Reduced 0.66%
13,214 $2.05 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $18,836 - $21,805
141 Added 1.07%
13,302 $1.98 Million
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $64,134 - $79,811
484 Added 3.82%
13,161 $1.77 Million
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $121,472 - $139,893
840 Added 7.1%
12,677 $2.02 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $508,289 - $609,572
3,675 Added 45.03%
11,837 $1.91 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $335,390 - $384,671
2,499 Added 44.13%
8,162 $1.1 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $419,052 - $532,753
3,045 Added 116.31%
5,663 $867,000
Q1 2022

Apr 18, 2022

BUY
$131.98 - $163.75 $345,523 - $428,697
2,618 New
2,618 $424,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Matrix Trust CO Portfolio

Follow Matrix Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Trust CO with notifications on news.